Clinical evaluation of recombinant interferon alfa-2a (Roferon-A) in metastatic melanoma using two different schedules .

Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

1980 • 503 citations

Interferons in the treatment of human cancer.

1984 • 334 citations

Interferon therapy in cancer: from imaginon to interferon.

1986 • 189 citations

Comparison of Intramuscular and Intravenous Recombinant Alpha-2 Interferon in Melanoma and Other Cancers

1985 • 173 citations

Phase II study of recombinant leukocyte a interferon (rIFN-αA) in disseminated malignant melanoma

1984 • 140 citations

Results with methyl-CCNU and DTIC in metastatic melanoma

1977 • 99 citations

Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma.

1984 • 93 citations

Interferons in the treatment of malignant melanoma. A review of recent trials

1986 • 87 citations

Integration of chemotherapy into combined modality therapy of solid tumors

1974 • 78 citations

Clinical phase II trial of recombinant dna interferon (interferon alfa 2b) in patients with metastatic malignant melanoma

1986 • 65 citations

Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trial.

1984 • 62 citations

Effects of recombinant leukocyte interferon (rIFN-α A) on tumour growth and immune responses in patients with metastatic melanoma

1985 • 57 citations

Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients.

1986 • 55 citations